|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.70 EUR | -1.34% |
|
-4.10% | -1.12% |
| 06-04 | Eurofins Scientific SE acquired High North Laboratories. | CI |
| 05-14 | Eurofins Scientific SE Develops And Offers New Solutions For Hantavirus Detection | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 515M | 487M | 1.22B | 614M | 791M | |||||
Trading Asset Securities, Total | 500K | 5.6M | 4.3M | 2M | 3M | |||||
Total Cash And Short Term Investments | 516M | 492M | 1.23B | 616M | 794M | |||||
Accounts Receivable, Total | 1.39B | 1.34B | 1.38B | 1.4B | 1.42B | |||||
Other Receivables | 192M | 256M | 236M | 208M | 223M | |||||
Total Receivables | 1.58B | 1.6B | 1.62B | 1.61B | 1.64B | |||||
Inventory | 154M | 146M | 139M | 142M | 139M | |||||
Prepaid Expenses | 68M | 78.3M | 84.9M | 85.7M | 76.1M | |||||
Other Current Assets, Total | - | -100K | - | -100K | - | |||||
Total Current Assets | 2.32B | 2.31B | 3.07B | 2.45B | 2.65B | |||||
Gross Property Plant And Equipment | 4.02B | 4.74B | 4.92B | 5.44B | 5.78B | |||||
Accumulated Depreciation | -2.19B | -2.57B | -2.62B | -2.88B | -3.02B | |||||
Net Property Plant And Equipment | 1.83B | 2.17B | 2.3B | 2.56B | 2.76B | |||||
Long-term Investments | 81.7M | 83.6M | 83.6M | 117M | 106M | |||||
Goodwill | 4.12B | 4.52B | 4.55B | 4.84B | 4.66B | |||||
Other Intangibles, Total | 896M | 919M | 796M | 788M | 690M | |||||
Deferred Tax Assets Long-Term | 90.9M | 75.7M | 93.8M | 130M | 116M | |||||
Other Long-Term Assets, Total | - | - | - | 200K | - | |||||
Total Assets | 9.33B | 10.08B | 10.89B | 10.89B | 10.99B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 323M | 347M | 339M | 376M | 399M | |||||
Accrued Expenses, Total | 860M | 836M | 823M | 868M | 907M | |||||
Short-term Borrowings | 80.3M | 78.5M | 300K | 83.1M | 247M | |||||
Current Portion of Long-Term Debt | 52.8M | 6.7M | 458M | 246M | 342M | |||||
Current Portion of Leases | 121M | 129M | 143M | 150M | 138M | |||||
Current Income Taxes Payable | 86M | 34.7M | 26.7M | 35.5M | 29.8M | |||||
Unearned Revenue Current, Total | 163M | 184M | 193M | 196M | 217M | |||||
Other Current Liabilities | 170M | 156M | 139M | 156M | 150M | |||||
Total Current Liabilities | 1.86B | 1.77B | 2.12B | 2.11B | 2.43B | |||||
Long-Term Debt | 2.08B | 2.71B | 2.89B | 2.67B | 3.41B | |||||
Long-Term Leases | 418M | 399M | 436M | 457M | 298M | |||||
Pension & Other Post Retirement Benefits | 75.5M | 59.5M | 66.2M | 66.4M | 64.2M | |||||
Deferred Tax Liability Non Current | 124M | 134M | 110M | 110M | 121M | |||||
Other Non Current Liabilities | 100M | 155M | 128M | 86M | 88.5M | |||||
Total Liabilities | 4.66B | 5.23B | 5.75B | 5.5B | 6.41B | |||||
Common Stock, Total | 1.9M | 1.9M | 1.9M | 1.9M | 1.8M | |||||
Retained Earnings | 1.96B | 2.33B | 2.39B | 2.69B | 3.02B | |||||
Treasury Stock | -3.6M | -14.2M | -54.9M | -308M | -299M | |||||
Comprehensive Income and Other | 2.68B | 2.46B | 2.74B | 2.95B | 1.82B | |||||
Total Common Equity | 4.65B | 4.78B | 5.08B | 5.34B | 4.54B | |||||
Minority Interest | 29.5M | 68.9M | 59.9M | 45.8M | 33.4M | |||||
Total Equity | 4.68B | 4.85B | 5.14B | 5.38B | 4.58B | |||||
Total Liabilities And Equity | 9.33B | 10.08B | 10.89B | 10.89B | 10.99B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 192M | 193M | 193M | 187M | 177M | |||||
ECS Total Common Shares Outstanding | 192M | 193M | 193M | 187M | 177M | |||||
Book Value / Share | 18.98 | 21.8 | 21.14 | 23.23 | 20.05 | |||||
Tangible Book Value | -363M | -661M | -270M | -290M | -804M | |||||
Tangible Book Value Per Share | -7.09 | -6.46 | -6.58 | -6.9 | -10.21 | |||||
Total Debt | 2.75B | 3.33B | 3.93B | 3.61B | 4.43B | |||||
Net Debt | 2.24B | 2.83B | 2.7B | 2.99B | 3.64B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 75.6M | 59.5M | 66.3M | 66.4M | 64.2M | |||||
Debt Equivalent Oper. Leases | 96.8M | 107M | 88M | 64M | - | |||||
Minority Interest, Total (Incl. Fin. Div) | 29.5M | 68.9M | 59.9M | 45.8M | 33.4M | |||||
Equity Method Investments, Total | 6.2M | 5.2M | 5.3M | 5.9M | 5.3M | |||||
Account Code - Inventory Valuation | 5 | 5 | 5 | - | 5 | |||||
Inventories - Others | 193M | 174M | 157M | 157M | 150M | |||||
Land - (BS) | 994M | 1.28B | 1.45B | - | 2.19B | |||||
Machinery, Total | 1.94B | 2.27B | 2.38B | 4.35B | 2.63B | |||||
Full Time Employees | 57.99K | 61.38K | 61.8K | 62.7K | 65.69K | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 55.1M | 57.9M | 63.3M | 60.5M | 58.9M |
- Stock Market
- Stocks
- ERF Stock
- Financials Eurofins Scientific SE
- Balance Sheet
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















